
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001
First allogeneic cell therapy to receive both FDA designations for the treatment of corneal edema secondary to corneal endothelial disease SEATTLE & CAMBRIDGE, Mass. & […]














